Crispr Theraptc (CRSP) Given $25.50 Consensus Target Price by Brokerages – Sports Perspectives
|
Crispr Theraptc (CRSP) Given $25.50 Consensus Target Price by Brokerages
Sports Perspectives Crispr Theraptc logo Shares of Crispr Theraptc (NASDAQ:CRSP) have been given a consensus broker rating score of 1.00 (Strong Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. Two analysts have rated the … |
